Immunitybio Inc (IBRX)
$2.87 -$0.20 (-6.58%) 4:38 PM 12/13/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$3.46B -
Day's Range
$2.82 - $3.13 -
Volume
5,778,335 -
52 Week Low / High
$3.10 - $10.53 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
- 2
- Strong Buy
- 0
- Buy
- 1
- Hold
- 0
- Sell
- 0
- Strong Sell
- $4.50
- Target Price
Company News
-
Phase 2 data presented at the World Conference on Lung Cancer showing a prolonged median overall survival of over 14 months in 2nd and 3rd line NSCLC cancer patients who progressed on checkpoint inhibitors such as KEYTRUDA (pembrolizumab) and OPDIVO (nivolumab) ANKTIVA plus KEYTRUDA or OPD...
-
ImmunityBio to Participate in the Jefferies London Healthcare Conference — Oct 21st, 2024
CULVER CITY, Calif., October 21, 2024--(BUSINESS WIRE)--Immunotherapy innovator ImmunityBio, Inc. (NASDAQ: IBRX), announced today that company executives will be participating in the Jefferies London Healthcare Conference, which is taking place November 19-21 at the Waldorf Hilton London. ...
-
ImmunityBio to Participate in the Jefferies London Healthcare Conference — Oct 21st, 2024
CULVER CITY, Calif., October 21, 2024--(BUSINESS WIRE)--Immunotherapy innovator ImmunityBio, Inc. (NASDAQ: IBRX), announced today that company executives will be participating in the Jefferies London Healthcare Conference, which is taking place November 19-21 at the Waldorf Hilton London. ...
-
ImmunityBio to Participate in the Jefferies London Healthcare Conference — Oct 21st, 2024
CULVER CITY, Calif., October 21, 2024--(BUSINESS WIRE)--Immunotherapy innovator ImmunityBio, Inc. (NASDAQ: IBRX), announced today that company executives will be participating in the Jefferies London Healthcare Conference, which is taking place November 19-21 at the Waldorf Hilton London. ...
-
ImmunityBio to Participate in the Jefferies London Healthcare Conference — Oct 21st, 2024
CULVER CITY, Calif., October 21, 2024--(BUSINESS WIRE)--Immunotherapy innovator ImmunityBio, Inc. (NASDAQ: IBRX), announced today that company executives will be participating in the Jefferies London Healthcare Conference, which is taking place November 19-21 at the Waldorf Hilton London. ...
-
ImmunityBio to Participate in the Jefferies London Healthcare Conference — Oct 21st, 2024
CULVER CITY, Calif., October 21, 2024--(BUSINESS WIRE)--Immunotherapy innovator ImmunityBio, Inc. (NASDAQ: IBRX), announced today that company executives will be participating in the Jefferies London Healthcare Conference, which is taking place November 19-21 at the Waldorf Hilton London. ...
-
ImmunityBio to Participate in the Jefferies London Healthcare Conference — Oct 21st, 2024
CULVER CITY, Calif., October 21, 2024--(BUSINESS WIRE)--Immunotherapy innovator ImmunityBio, Inc. (NASDAQ: IBRX), announced today that company executives will be participating in the Jefferies London Healthcare Conference, which is taking place November 19-21 at the Waldorf Hilton London. ...
-
ImmunityBio to Participate in the Jefferies London Healthcare Conference — Oct 21st, 2024
CULVER CITY, Calif., October 21, 2024--(BUSINESS WIRE)--Immunotherapy innovator ImmunityBio, Inc. (NASDAQ: IBRX), announced today that company executives will be participating in the Jefferies London Healthcare Conference, which is taking place November 19-21 at the Waldorf Hilton London. ...
-
ImmunityBio to Participate in the Jefferies London Healthcare Conference — Oct 21st, 2024
CULVER CITY, Calif., October 21, 2024--(BUSINESS WIRE)--Immunotherapy innovator ImmunityBio, Inc. (NASDAQ: IBRX), announced today that company executives will be participating in the Jefferies London Healthcare Conference, which is taking place November 19-21 at the Waldorf Hilton London. ...
-
ImmunityBio to Participate in the Jefferies London Healthcare Conference — Oct 21st, 2024
CULVER CITY, Calif., October 21, 2024--(BUSINESS WIRE)--Immunotherapy innovator ImmunityBio, Inc. (NASDAQ: IBRX), announced today that company executives will be participating in the Jefferies London Healthcare Conference, which is taking place November 19-21 at the Waldorf Hilton London. ...
-
ImmunityBio to Participate in the Jefferies London Healthcare Conference — Oct 21st, 2024
CULVER CITY, Calif., October 21, 2024--(BUSINESS WIRE)--Immunotherapy innovator ImmunityBio, Inc. (NASDAQ: IBRX), announced today that company executives will be participating in the Jefferies London Healthcare Conference, which is taking place November 19-21 at the Waldorf Hilton London. ...
-
ImmunityBio to Participate in the Jefferies London Healthcare Conference — Oct 21st, 2024
CULVER CITY, Calif., October 21, 2024--(BUSINESS WIRE)--Immunotherapy innovator ImmunityBio, Inc. (NASDAQ: IBRX), announced today that company executives will be participating in the Jefferies London Healthcare Conference, which is taking place November 19-21 at the Waldorf Hilton London. ...
-
ImmunityBio to Participate in the Jefferies London Healthcare Conference — Oct 21st, 2024
CULVER CITY, Calif., October 21, 2024--(BUSINESS WIRE)--Immunotherapy innovator ImmunityBio, Inc. (NASDAQ: IBRX), announced today that company executives will be participating in the Jefferies London Healthcare Conference, which is taking place November 19-21 at the Waldorf Hilton London. ...
-
ImmunityBio to Participate in the Jefferies London Healthcare Conference — Oct 21st, 2024
CULVER CITY, Calif., October 21, 2024--(BUSINESS WIRE)--Immunotherapy innovator ImmunityBio, Inc. (NASDAQ: IBRX), announced today that company executives will be participating in the Jefferies London Healthcare Conference, which is taking place November 19-21 at the Waldorf Hilton London. ...
Portfolio
Comprised of 1 portfolios